Elan spinoff Prothena hires two for executive team

... and CEO Dale Schenk , who was chief scientific officer at Elan before the clinical failure of its experimental Alzheimer's disease drug bapineuzumab. Schenk and Koller aren't the only former Elan employees at Prothena's core. Prothena Chairman Lars ...

http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/03/prothena-elan-bapineuzumab.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_38+%28Health+Care+Regulation+Industry+News%29